A leading pharmaceutical company is claiming it has made a breakthrough in the management of diabetes, in the shape of a device which attaches to a smartphone.
The iBGStar glucose monitor allows suffers to check their blood sugar levels at any time, which is vital for managing the condition.
As it stands, blood glucose monitors (BGMs) are palm-sized devices that test tiny drops of blood obtained by pricking the skin.
The iBGStar monitor, which plugs into the Apple iPhone and iPod touch, works in the same way, but is just one inch long. The results appear on the screen after software carries out the analysis.
The £48 monitor comes with a free Diabetes Manager App, enabling users to store, track and analyse medical data. It is being rolled out across Boots stores.
Andrew Hockey, medical director for diabetes at the pharmaceutical company Sanofi, which produces the iBGStar, said: “It harnesses the power of the latest technology to empower people with diabetes to manage their condition on a day-to-day basis”.
The monitor, which Dr Hockey calls “huge step forward”, also allows uses to factor in information such as carbohydrate intake, insulin injections and exercise. More than 2.9 million people in the UK suffer from diabetes.